| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36c0172f6059c0b200188dba42db7fa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dc051e7b094da349100e29cc006d50b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0657 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
| filingDate |
2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19ddcaa513a46a26b31b4b5c251ae0ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21cbda9cce24de19c704996c7235648d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50490fe32dd598b69693e6d7f1fcc9be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4c3688829438e5826fcf626ebfba31e |
| publicationDate |
2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015004539-A2 |
| titleOfInvention |
Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins ln-511, ln-521 and ln-221 |
| abstract |
The present disclosure describes methods of differentiating cardiomyocyte progenitor cells and mature cardiomyocyte cells from pluripotent stem cells. The methods may include differentiating pluripotent stems cells on a substrate including (i) laminin-511 or 521 and (ii) laminin 221. The mature cardiomyocyte cells produced by the method may form a human heart muscle cell line for use in regenerative cardiology. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11713448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023087109-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10683486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017039445-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108265029-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017072580-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017181166-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3964565-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3196297-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10696948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018236289-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3504321-A4 |
| priorityDate |
2013-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |